Amphotericin B

Efficacy of an oral lipid nanocrystal formulation of amphotericin B (MAT2203) in the neutropenic mouse model of pulmonary mucormycosis

Gu Y, Gebremariam T, Alkhazraji S, Youssef E, El-Gamal S, Matkovits T, Cobb J, Mannino R, Ibrahim AS. Efficacy of an oral lipid nanocrystal formulation[...]

By sjmartinez • May 1, 2024

Part 2: Mucormycosis: Focus on Therapy

Lynch JP 3rd, Zhanel GG. Part 2: Mucormycosis: Focus on Therapy. Expert Rev Anti Infect Ther. 2023 Jun 10. doi: 10.1080/14787210.2023.2224564. Epub ahead of print.[...]

By sjmartinez • June 12, 2023